FDA decision expected by PDUFA target action date of March 22, 2023
If approved, rezafungin will be the first new drug for the treatment of candidemia and invasive candidiasis in over a decade
https://finance.yahoo.com/news/cidara-therapeutics-melinta-therapeutics-announce-120000219.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.